M. Traitement-de-référence-des and :. Et-potentiellement-curatives, 24 i. La chirurgie seule

.. Alternatives-À-la-chirurgie-curative, 30 i. L'ablation per-cutanée, La radiofréquence (RF), vol.31

L. Cyberknife and ®. , 35 c. Résultats de la RTS sur les tumeurs hépatiques 36 d. Dose tumoricide 38 f. Doses de contrainte aux organes à risque (OAR), p.41

T. Complications, 66 i. Complications de la pose des grains fiduciels, Discussion, vol.66, p.68

W. L. Grundmann-e, T. J. Hartveit-f, . Moberg-i, . Eder-m, . M. Fenoglio-preiser-c et al., Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies, J Pathol, vol.150, issue.3, pp.195-203, 1986.

M. S. Lepage-c, C. O. Hatem-c, and F. J. Bouvier-a, Epidemiology and management of liver metastases from colorectal cancer, Ann Surg, vol.244, issue.2, pp.254-259, 2006.

P. T. Schulick-r and C. M. , Expanding criteria for resectability of colorectal liver metastases, Oncologist, vol.13, issue.1, pp.51-64, 2008.

F. Y. Fortner-j, S. R. Brennan-m, and . H. Blumgart-l, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases, Ann Surg, vol.230, issue.3, pp.309-318, 1999.

N. B. Guiguet-m, . C. Vaillant-j, . Balladur-p, . Boudjema-k, and . Bachellier-p, Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie, Cancer, vol.77, issue.7, pp.1254-1262, 1996.

E. G. Grazi-g, R. M. Cescon-m, G. A. Varotti-g, . Del-gaudio-m, and . Nardo-b, Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival, Arch Surg, vol.137, issue.10, pp.1187-1192, 2002.

M. M. Makuuchi-m, . Torzilli-g, K. S. Takayama-t, and Y. J. Kosuge-t, Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: longterm results, Ann Surg, vol.231, issue.4, pp.487-499, 2000.

A. A. Navarra-g, T. J. Basaglia-e, . Healey-a, . Spalding-d, . Canelo-r et al., Results of major hepatectomy without vascular clamping using radiofrequency-assisted technique compared with total vascular exclusion, Hepatogastroenterology, vol.54, issue.75, pp.806-809, 2007.

B. S. Salabert-a, . Penna-c, J. C. Karoui-m, and R. P. , Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients, Surgery, vol.140, issue.3, pp.396-403, 2006.

D. J. Haas-r, W. D. Flores-e, A. D. , and C. D. Adam-r, R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?, Ann Surg, vol.248, issue.4, pp.626-637, 2008.

G. K. Sheth-h, . Kumar-y, D. B. Sharma-d, . N. Rahbari-n, M. A. Koch-m et al., Methods of vascular occlusion for elective liver resections Portal triad clamping versus vascular exclusion for vascular control during hepatic resection: a systematic review and metaanalysis, Cochrane Database Syst Rev J Gastrointest Surg, vol.13, issue.3, pp.558-568, 2009.

Z. D. Mullen-j, P. K. Abdalla-e, A. A. , M. A. Curley-s, C. L. Mentha-g et al., Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases, J Gastrointest Surg, vol.10, issue.1, pp.86-94, 2006.

S. J. Stang-r, . Altendorf-hofmann-a, and . Paul-m, Resection of colorectal liver metastases, World J Surg, vol.19, issue.1, pp.59-71, 1995.

N. B. Sorbye-h, . Glimelius-b, . J. Poston-g, R. M. Schlag-p, P. O. Bechstein-w et al., Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, Lancet, vol.371, issue.9617, pp.1007-1016, 2008.

B. J. Hiramatsu-k, . Benoist-s, . Massault-p, and . Sauvanet-a, Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection, J Am Coll Surg, vol.191, issue.1, pp.38-46, 2000.

C. B. Jenkins-r, J. D. Steele-g, L. W. Stone-m, J. V. Mcdermott-w, . Bothe-a et al., Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome, Ann Surg, vol.227, issue.4, pp.566-571, 1998.

A. Scheele-j and C. T. , A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma [Standards, Options, and Recommendations for the surveillance after treatment in cancer of the colon. The SOR Working Group, Cancer du Colon" de la Federation Nationale des Centres de Lutte Contre le Cancer]. Bull Cancer, pp.165-192, 1998.

L. F. Navarro-f, Y. M. , D. J. , and R. P. , Therapeutic management of hepatic metastases from colorectal cancers], Gastroenterol Clin Biol, vol.27, issue.2, p.7, 2003.

A. R. Delvart-v, P. G. Valeanu-a, C. D. , A. D. , G. S. et al., Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival, Ann Surg, vol.240, issue.4, pp.644-657, 2004.

F. F. , R. J. Goodwin-j, L. D. Hawkins-w, and . M. Strasberg-s, Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases, J Am Coll Surg, vol.200, issue.6, pp.845-853, 2005.

N. H. Oussoultzoglou-e, R. E. , C. S. Chenard-neu-m, . Dufour-p, and . Bachellier-p, Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy, Ann Surg, vol.247, issue.1, pp.118-124, 2008.

R. , A. V. Sartoretti-p, R. A. Brezault-c, C. M. Le, . Dousset-b et al., Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer, Ann Oncol, vol.15, issue.3, pp.460-466, 2004.

V. J. Pawlik-t, R. D. Wu-t, . Zorzi-d, . M. Hoff-p, . Q. Xiong-h et al., Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases, J Clin Oncol, vol.24, issue.13, pp.2065-2072, 2006.

V. J. , C. A. Do-k, . M. Bilimoria-m, C. J. Fenstermacher-m, A. G. Hicks-m et al., Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations, Surgery, vol.127, issue.5, pp.512-519, 2000.

P. T. Izzo-f, M. S. Cohen-d, and . A. Curley-s, Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients, Ann Surg Oncol, vol.10, issue.9, pp.1059-1069, 2003.

G. S. Gazelle-g, D. S. , R. W. Mueller-p, and . I. Rosenthal-d, Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume, Acad Radiol, vol.2, issue.5, pp.399-404, 1995.

F. P. , T. J. , J. J. Burki-f, F. J. , C. J. et al., Place de la radiofréquence dans la destruction des tumeurs du foie Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence, Am J Surg, vol.200, issue.4, pp.435-439, 2006.

D. B. Siriwardena-a, M. A. Van-tilborg-a, . Sietses-c, W. J. Van, M. M. Meijer-s et al., Radiofrequency ablation of liver tumours: systematic review Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention, Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings, pp.550-560, 2003.

S. L. Livraghi-t, . N. Goldberg-s, . Ierace-t, . Meloni-f, C. L. Dellanoce-m et al., Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients, Radiology, vol.221, issue.1, pp.159-166, 2001.

A. M. , C. G. Castro-j, S. W. , P. S. Woodruff-k, and . Kessler-m, Dose volume histogram analysis of liver radiation tolerance, Int J Radiat Oncol Biol Phys, vol.12, issue.1, pp.31-35, 1986.

M. F. Girard-n, K. A. Beziat-c, . Khodri-m, and M. P. Trepo-c, Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma noneligible for curative therapies--mature results of the French Phase II RTF-1 trial, Int J Radiat Oncol Biol Phys, vol.66, issue.4, pp.1152-1158, 2006.

K. A. Irsn-fiche, C. M. , M. A. Milano-m, . C. Schell-m, and . Okunieff-p, Radiothérapie stéréotaxique. disponible sur: www.irsn.fr/FR/Actualites_presse/Comm 43 HAS Radiothérapie stéréotaxique en conditions extracrâniennes. Rapport HAS Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases, Int J Radiat Oncol Biol Phys, vol.44, issue.3, pp.793-798, 2006.

H. M. , R. H. , T. A. Hansen, . Ohlhuis-l, . Petersen-j et al., Phase II study on stereotactic body radiotherapy of colorectal metastases, Acta Oncol, vol.45, issue.7, pp.823-830, 2006.

M. X. Ambrosino, . Polistina-f, . Costantin-g, . Francescon-p, . Guglielmi-r et al., Have we established a stereotactic body radiotherapy regimen for liver metastases? n° 22, e40; author reply e41. 47 Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results, J Clin Oncol Anticancer Res, vol.27, issue.8, pp.3381-3384, 2009.

G. K. , E. D. Yao-m, B. F. Kunos-c, . Singh-d, S. J. Siegel-c et al., Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies, HPB Surg Article ID Int J Radiat Oncol Biol Phys, vol.309780, issue.2, pp.486-493, 2010.

M. R. Schefter-t, G. L. , Z. R. , and G. D. Kavanagh-b, Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy, Int J Radiat Oncol Biol Phys, vol.73, issue.1, pp.112-118, 2009.

O. C. , W. J. Kavanagh-b, F. W. Mccarter-m, C. H. , G. L. et al., Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy, Int J Radiat Oncol Biol Phys, vol.73, issue.5, pp.1414-1424, 2009.

D. L. , N. D. Balter-j, L. J. Mcginn-c, and H. R. Ten, Analysis of radiation-induced liver disease using the Lyman NTCP model, Int J Radiat Oncol Biol Phys, vol.53, issue.4, pp.810-821, 2002.

R. A. Mendez, W. W. Hussain-s, P. J. De, . J. Heijmen-b, N. C. Nowak-p et al., Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study, Acta Oncologica, vol.62, issue.1, pp.831-837, 2006.
DOI : 10.1016/j.ijrobp.2005.01.002

H. K. , H. H. Bahner-m, . Lohr-f, . Hoss-a, . Van-kaick-g et al., Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors, Int J Radiat Oncol Biol Phys, vol.57, issue.2, pp.444-451, 2003.

T. P. , A. S. , E. E. , W. J. Kaplan-r, . Rubinstein-l et al., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Natl Cancer Inst, vol.92, issue.3, pp.205-216, 2000.

M. X. Hollebecque-a, B. F. Le, D. S. Duburque-c, . Lacornerie-t, and A. A. Bonodeau-f, Stereotactic radiotherapy with respiratory motion tracking for liver tumors: 20 months experience, Int J Radiat Oncol Biol Phys, vol.75, issue.3, p.260, 2009.